Related Experiment Video
Updated: Oct 5, 2025

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
Published on: December 18, 2012
Covid-19 vaccination and possible link to Herpes zoster
D R Lazzaro1, R Ramachandran1, E Cohen1
1NYU Langone Medical Center: NYU Langone Health, United States.
Purpose:
To report 3 otherwise healthy patients with Herpes zoster reactivation shortly after administration of a mRNA vaccine against the novel COVID-19 virus.
Observations:
Patient 1 is a 54 year old who presented with Herpes zoster meningitis complicated by enhancing nodular leptomeningeal lesions of the spinal cord. The subsequent two patients had Herpes zoster ophthalmicus of the cornea (Case 2) and eyelid (Case 3). All three presented within 2 weeks of receiving the Pfizer/BioNTech COVID-19 vaccine.
Conclusions:
Herpes zoster may be a side effect of m RNA vaccination against the Sars-CoV2 vaccine and requires further investigation.
Insights
Herpes zoster reactivation occurred in three healthy patients within two weeks of receiving the mRNA COVID-19 vaccine. Further investigation is needed to determine if herpes zoster is a side effect of mRNA SARS-CoV-2 vaccination.
Area of Science:
- Neurology
- Immunology
- Infectious Diseases
Background:
- The novel COVID-19 virus (SARS-CoV-2) prompted rapid development of mRNA vaccines.
- Herpes zoster, a viral infection caused by the varicella-zoster virus, can reactivate under certain conditions.
Observation:
- Three otherwise healthy patients developed herpes zoster reactivation shortly after receiving the Pfizer/BioNTech mRNA COVID-19 vaccine.
- Presentations included herpes zoster meningitis, herpes zoster ophthalmicus involving the cornea, and herpes zoster affecting the eyelid.
Findings:
- All three cases presented within two weeks of vaccination.
- The neurological and ophthalmological manifestations suggest a potential link between mRNA vaccination and herpes zoster reactivation.
Implications:
- Herpes zoster reactivation may be an infrequent side effect of mRNA SARS-CoV-2 vaccination.
- Clinicians should consider herpes zoster in patients presenting with suggestive symptoms post-vaccination.
- Further research is warranted to establish causality and understand the mechanisms involved.
More Related Videos
08:04Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Published on: July 9, 2014
12:22A Primary Neuron Culture System for the Study of Herpes Simplex Virus Latency and Reactivation
Published on: April 2, 2012
Related Concept Videos
Vaccinations
Cross-reactivity
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Viral Recombination